Limited coverage drugs – sarilumab

Last updated on February 6, 2024

Special Authority requests can now be submitted online. It's simple and quick!

Learn more or log in

Generic name	sarilumab
Strength	150 mg/1.14 mL 200 mg/ 1.14 mL
Form	pre-filled syringe or pre-filled pen for subcutaneous injection

Generic name

sarilumab

Strength

150 mg/1.14 mL

200 mg/ 1.14 mL

Form

pre-filled syringe or pre-filled pen for subcutaneous injection

Special Authority criteria	Approval period
For the treatment of rheumatoid arthritis (RA) when: Prescribed by a rheumatologist AND Prescribed according to established criteria (as indicated on the applicable Special Authority form below)	First approval: 1 year Renewal: 1 year

Special Authority criteria

Approval period

For the treatment of rheumatoid arthritis (RA) when:

Prescribed by a rheumatologist

AND

Prescribed according to established criteria (as indicated on the applicable Special Authority form below)

First approval: 1 year

Renewal: 1 year

Practitioner exemptions

None

Special notes

PharmaCare covers a maximum 28-day supply of sarilumab per fill. Coverage is limited to 200 mg or 150 mg every 2 weeks

Special Authority requests

Did you find what you were looking for?

The B.C. Public Service acknowledges the territories of First Nations around B.C. and is grateful to carry out our work on these lands. We acknowledge the rights, interests, priorities, and concerns of all Indigenous Peoples - First Nations, Métis, and Inuit - respecting and acknowledging their distinct cultures, histories, rights, laws, and governments.

More topics

Limited coverage drugs – sarilumab

Practitioner exemptions

Special notes

Special Authority requests